LAS VEGAS, Sept. 21, 2021 /PRNewswire/ -- The increase in the Cardiopulmonary Bypass Equipment market can be attributed to MedTech companies increasing their R&D to manufacture advanced cardiopulmonary products and launch better products and also because of the increase in the prevalence of cardiovascular diseases, decrease in heart muscle elasticity, change in lifestyles leading to rising in the burden of cardiovascular diseases, and increasing geriatric population.

DelveInsight has recently published "Cardiopulmonary Bypass Equipment Market Insight, Competitive Landscape & Forecast – 2026," report that covers key areas transforming the Cardiopulmonary Bypass Equipment market landscape. The Cardiopulmonary Bypass Equipment market report delivers an in-depth understanding of the Cardiopulmonary Bypass Equipment, their usage, forecasted epidemiology from 2018 to 2026, historical and forecasted Cardiopulmonary Bypass Equipment market trends.

The report also covers the Cardiopulmonary Bypass Equipment market drivers, market barriers and unmet medical in the market domain to curate the best of the opportunities in the Cardiopulmonary Bypass Equipment market.

Interested in knowing how the Cardiopulmonary Bypass Equipment Market will be growing by 2026? Get the snapshot: Cardiopulmonary Bypass Equipment Market

This report provides an in-depth market understanding for cardiopulmonary bypass equipment which will further benefit the competitors or stakeholders operating in the Cardiopulmonary Bypass Equipment market arena. 

Cardiopulmonary Bypass: Overview

Cardiopulmonary bypass (CPB), a heart-lung machine or pump, is a machine that temporarily takes over the function of the heart and lungs during any bloodless surgery. It maintains the circulation of blood and the oxygen content of the patient's body and is operated by perfusionists. The CPB is a form of extracorporeal circulation and is required during surgeries that require the opening of the chambers of the heart such as cardiac valve repair and/or replacement (aortic valve, mitral valve, tricuspid valve, pulmonic valve), coronary artery bypass surgery, and repair of large septal defects (atrial septal defect, ventricular septal defect, atrioventricular septal defect), among others. The machine pumps the blood and, using an oxygenator, allows red blood cells to pick up oxygen, as well as allowing carbon dioxide levels to decrease, mimicking heart and lung function. 

Know more about the technique and recent advancements @ Cardiopulmonary Bypass Equipment Market Analysis 

Cardiopulmonary Bypass Equipment Market Insights 

Over the years, Cardiopulmonary Bypass Equipments have helped in making significant advances in the management of severe respiratory failure as well as in the field of cardiac surgeries. The increasing number of cardiology disorders in an increasing population is anticipated to lead to a rise in demand for the equipment, thereby pushing the growth of the  Cardiopulmonary Bypass Equipment market size. 

Geography-wise Cardiopulmonary Bypass Equipment Market Share Analysis

Geographically, the global Cardiopulmonary Bypass Equipment analysis is done for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share North America currently leads the global market and is expected to remain constant during the forecast period. However, the supremacy of North America will be evidently challenged by the Asia-Pacific market. This domination is due to the growing demand because of the growing number of surgeries, and demand for advanced technologies in Cardiopulmonary Bypass Equipment in the region. There are great opportunities for Cardiopulmonary Bypass Equipment market penetration for the countries like India, and China to the major companies already having a grip in developed regions.

Request for a sample report to learn more about the change trends in specific geographies at Cardiopulmonary Bypass Equipment Market Share 

Impact of COVID-19 on Cardiopulmonary Bypass Equipment Market 

The demand for Cardiopulmonary Bypass Equipment is primarily motivated by the outbreak of the Covid-19 pandemic. The elective surgeries were delayed in order to curb the infection, but as the hospitals are re-opening and most cardiac surgical patients present in a more urgent manner which elevates the critical nature for intervention, which may make the surgical decision inevitable. Cardiopulmonary Bypass Equipment assists in extracorporeal circulation and physiologic gas exchange of the patient's blood for more than 6 hours. Hence, as a preventive measure, governments across the world have promoted the manufacturing of better and efficient CPB devices. This is expected to drive the cardiopulmonary bypass equipment market in the forecasted years. 

As per the recent survey (2019), approximately 200,000 coronary artery bypass graft surgeries take place each year in the US, requiring cardiopulmonary bypass equipment, such as heart-lung machines and oxygenators. It has been estimated that 1.5 million people in Britain suffer from faulty mitral heart valves, requiring heart surgery. Thus, all these factors are projected to drive the growth of the market for cardiopulmonary bypass equipment.

Discuss more the short/long-term impact of COVID-10 at Cardiopulmonary Bypass Equipment Market Share Analysis and Forecast 

Cardiopulmonary Bypass Equipment Market Segmentation

The report proffers Cardiopulmonary Bypass Equipment market segmentation as follows:

• By Product
  • Heart–Lung Machines
  • Oxygenators
  • Autotransfusion Systems
  • Others
• By Application
  • Cardiovascular
  • Respiratory
  • Hemodialysis
  • Others
• By End-User
  • Hospitals
  • Specialty Clinics
  • Dialysis Centers
  • Ambulatory Surgery Centers
• By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Cardiopulmonary Bypass Equipment Market Report Scope

• Study Period: 2018-2026
• Key Companies: Medtronic PLC, LivaNova PLC, MAQUET Holding B.V. & Co. KG., Terumo Corporation, Braile Biomedica Ltda, Tianjin Medical, Senko Medical Instrument Manufacturing Co. Ltd., and others.
• Segmentation: By Product, By Application, By End-User, and By Geography
• Geography Covered: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
• Analysis: The Cardiopulmonary Bypass Equipment market is expected to grow at a CAGR of 4.13% and will reach USD 389.14 million by 2026.

Cardiopulmonary Bypass Equipment Market Report: Table of Contents

Related Reports

Diagnostic Imaging Equipment Market

DelveInsight's 'Diagnostic Imaging Equipment Market Insights, Competitive Landscape and Market Forecast - 2026' report offers a key analysis of the market domain, therapies and key companies including GE Healthcare, Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Hologic Corporation, Koninklijke Philips N.V., Siemens Healthineers, and others. 

Pulse Oximeter Market

DelveInsight's 'Pulse Oximeter Market Insights, Competitive Landscape and Market Forecast - 2026' report offers a key analysis of the market domain, therapies and key companies including Medtronic, Nonin Medical Inc., Lepu Medical Technology, TytoCare Ltd., VYAIRE, OMRON Corporation, and others. 

Neurostimulation Devices Market

DelveInsight's 'Neurostimulation Devices Market Insights, Competitive Landscape and Market Forecast - 2026' report offers a key analysis of the market domain, therapies and key companies including Medtronic PLC, Cyberonics, Boston Scientific Corporation, Abbott Laboratories, Aleva neurotherapeutics SA, and others. 

Neuromodulation Devices Market

DelveInsight's 'Neuromodulation Market Insights, Competitive Landscape and Market Forecast - 2026' report offers a key analysis of the market domain, therapies and key companies including Medtronic, Boston Scientific Corporation, Abbott, LivaNova, NeuroSigma, and others. 

Pain Management Devices Market

DelveInsight's 'Pulse Oximeter Market Insights, Competitive Landscape and Market Forecast - 2026' report offers a key analysis of the market domain, therapies and key companies including Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., and others. 

Related Posts 

MedTech Industry and Artificial Intelligence

Chronic Pain Associated With Painful Diabetic Neuropathy Market and Medically Advanced Treatment Options 

Benign Prostatic Hyperplasia Devices Market

Discover how DelveInsight helped US-based pharmaceutical companies advance in the Biosimilar Market landscape in Europe through its Pharmaceutical and Healthcare Market Due Diligence Services and Go-to-market strategies. 

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

For more insights, visit Pharma, Healthcare, and Biotech News 

Contact Us

Shruti Thakur 
[email protected] 
+1(919)321-6187 
www.delveinsight.com

SOURCE DelveInsight Business Research, LLP